Grape Polyphenols Inhibit Akt/Mammalian Target of Rapamycin Signaling and Potentiate the Effects of Gefitinib in Breast Cancer
出版年份 2012 全文链接
标题
Grape Polyphenols Inhibit Akt/Mammalian Target of Rapamycin Signaling and Potentiate the Effects of Gefitinib in Breast Cancer
作者
关键词
-
出版物
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Volume 64, Issue 7, Pages 1058-1069
出版商
Informa UK Limited
发表日期
2012-10-12
DOI
10.1080/01635581.2012.716898
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combined Resveratrol, Quercetin, and Catechin Treatment Reduces Breast Tumor Growth in a Nude Mouse Model
- (2014) Alexander Schlachterman et al. Translational Oncology
- Distribution of Resveratrol Metabolites in Liver, Adipose Tissue, and Skeletal Muscle in Rats Fed Different Doses of This Polyphenol
- (2012) Cristina Andres-Lacueva et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids
- (2012) Francisco Perez-Vizcaino et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Polyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer
- (2012) Sebastiano Cimino et al. Oxidative Medicine and Cellular Longevity
- Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin
- (2012) Mohd Askandar Iqbal et al. PLoS One
- Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor
- (2011) Glenn S. Van Aller et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Quercetin protects against pulmonary oxidant stress via heme oxygenase-1 induction in lung epithelial cells
- (2011) Yuta Hayashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity
- (2011) Wieslawa H Dragowska et al. BMC CANCER
- Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer
- (2011) Mogens Bernsdorf et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
- (2011) G. Somlo et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
- (2011) Mogens Bernsdorf et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
- (2011) Suleiman Massarweh et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: A Randomized Phase II Study
- (2011) C. K. Osborne et al. CLINICAL CANCER RESEARCH
- mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy
- (2011) Ruth O'Regan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties
- (2011) Silvina B. Lotito et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
- (2011) Takayuki Kosaka et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Assessment of Some Australian Red Wines for Price, Phenolic Content, Antioxidant Activity, and Vintage in Relation to Functional Food Prospects
- (2011) Yung J. Yoo et al. JOURNAL OF FOOD SCIENCE
- Grape seed extract upregulates p21 (Cip1) through redox-mediated activation of ERK1/2 and posttranscriptional regulation leading to cell cycle arrest in colon carcinoma HT29 cells
- (2011) Manjinder Kaur et al. MOLECULAR CARCINOGENESIS
- Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
- (2010) Lev M. Berstein et al. BREAST CANCER RESEARCH AND TREATMENT
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
- (2010) Izet M. Kapetanovic et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling
- (2010) Xin He et al. CANCER LETTERS
- Quercetin Potentiates UVB-Induced c-Fos Expression: Implications for Its Use as a Chemopreventive Agent
- (2010) E. R. Olson et al. Cancer Prevention Research
- Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
- (2010) A. Puissant et al. CANCER RESEARCH
- Inhibition of the PI3K Pathway: Hope We Can Believe in?
- (2010) M. S. van der Heijden et al. CLINICAL CANCER RESEARCH
- Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
- (2010) M. Cristofanilli et al. CLINICAL CANCER RESEARCH
- Metformin: A Therapeutic Opportunity in Breast Cancer
- (2010) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglyconein vivo
- (2010) Junji Terao et al. Food & Function
- LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
- (2009) R. J. Shaw Acta Physiologica
- Grape seed extract inhibits VEGF expression via reducing HIF-1 protein expression
- (2009) J. Lu et al. CARCINOGENESIS
- Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols
- (2009) Linette Castillo-Pichardo et al. CLINICAL & EXPERIMENTAL METASTASIS
- Toxicity of Targeted Therapy in Non–Small-Cell Lung Cancer Management
- (2009) Serena Ricciardi et al. Clinical Lung Cancer
- AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
- (2009) Aaron K. F. Wong et al. CLINICAL SCIENCE
- AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin
- (2009) Yun-Kyoung Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Anticancer and Cancer Chemopreventive Potential of Grape Seed Extract and Other Grape-Based Products
- (2009) Manjinder Kaur et al. JOURNAL OF NUTRITION
- AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols
- (2009) Jin-Taek Hwang et al. New Biotechnology
- BRMS1 Suppresses Breast Cancer Experimental Metastasis to Multiple Organs by Inhibiting Several Steps of the Metastatic Process
- (2008) Pushkar A. Phadke et al. AMERICAN JOURNAL OF PATHOLOGY
- Acquired resistance to tyrosine kinase inhibitors during cancer therapy
- (2008) Jeffrey A Engelman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Quercetin-induced ubiquitination and down-regulation of Her-2/neu
- (2008) Jae-Hoon Jeong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Comparison of delphinidin, quercetin and (–)‐epigallocatechin‐3‐gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation
- (2008) Diana Fridrich et al. MOLECULAR NUTRITION & FOOD RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now